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Abstract
Sodium	channels	are	voltage-gated	sodium-selective	ion	channels	present	in	the	membrane	of	most
excitable	cells.	Sodium	channels	comprise	of	one	pore-forming	α	subunit,	which	may	be	associated
with	either	one	or	two	β	subunits	[177].	α-Subunits	consist	of	four	homologous	domains	(I-IV),	each
containing	six	transmembrane	segments	(S1-S6)	and	a	pore-forming	loop.	The	positively	charged
fourth	transmembrane	segment	(S4)	acts	as	a	voltage	sensor	and	is	involved	in	channel	gating.	The
crystal	structure	of	the	bacterial	NavAb	channel	has	revealed	a	number	of	novel	structural	features
compared	to	earlier	potassium	channel	structures	including	a	short	selectivity	filter	with	ion
selectivity	determined	by	interactions	with	glutamate	side	chains	[274].	Interestingly,	the	pore	region
is	penetrated	by	fatty	acyl	chains	that	extend	into	the	central	cavity	which	may	allow	the	entry	of
small,	hydrophobic	pore-blocking	drugs	[274].	Auxiliary	β1,	β2,	β3	and	β4	subunits	consist	of	a	large
extracellular	N-terminal	domain,	a	single	transmembrane	segment	and	a	shorter	cytoplasmic	domain.
The	nomenclature	for	sodium	channels	was	proposed	by	Goldin	et	al.,	(2000)	[144]	and
approved	by	the	NC-IUPHAR	Subcommittee	on	sodium	channels	(Catterall	et	al.,	2005,
[52]).
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